Traceable Opioid Material® Kits

Overview

The TOM Kits® product line provides reference materials for fentanyl compounds, synthetic opioids, and other emerging drugs of concern based, in part, on US Drug Enforcement Administration Emerging Threat Reports, the National Forensic Laboratory Information System, and the Center for Forensic Science Research and Education Scope and Trend Reports.

Traceable Opioid Material® Kits are reference materials and do not eliminate the need to meet analytical method requirements of other federal agencies or the need to comply with state and local regulations. Traceable Opioid Material® Kits are not for diagnostic use.

How to access Traceable Opioid Material® Kits

TOM Kits® products and services are available free of charge through vendors to public and private US laboratories. Proof of current Drug Enforcement Administration-controlled substance registration is required for scheduled products.

These materials are distributed by Cayman Chemical, an ISO-accredited reference material producer, to labs in the US and its territories. Labs eligible to apply for the EDP kit must have a valid DEA controlled substance registration for Schedule I controlled substances.

Available kits

Emergent Drug Panel (EDP) Kits

Fentanyl Analog Screening Kits (FAS) and Emergent Panels (No longer available)

Opioid Certified Reference Material Kit (Opioid CRM Kit) (No longer available)

Opioid Polysubstance Mix Kit (OPM Kit) (No longer available)

Publications

Designing Traceable Opioid Material* Kits to Improve Laboratory Testing during the U.S. Opioid Overdose Crisis

Application of the Fentanyl Analog Screening Kit toward the Identification of Emerging Synthetic Opioids in Human Plasma and Urine by LC-QTOF

A pilot PT scheme for external assessment of laboratory performance in testing synthetic opioid compounds in urine, plasma, and whole blood

Disclaimer

TRACEABLE OPIOID MATERIAL®, and TOM Kits® are registered marks of HHS.

Use of trade names and commercial sources is for identification only and does not constitute endorsement by the U.S. Department of Health and Human Services or the U.S. Centers for Disease Control and Prevention.